Has Husein Poonawala, MD received payments from drug or device companies?

Yes. Drug and device makers reported $4,211 in general payments to Husein Poonawala, MD across 64 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Husein Poonawala, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Husein Poonawala, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Husein Poonawala, MD

Vascular & Interventional Radiology · Flower Mound, TXNPI 1275823890

Payments from drug & device makers

$4,211in general payments, 2019–2025

Across 64 payments — averaging $65.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Angiodynamics, Inc.$2K
Medtronic$871
Bard Peripheral Vascular, Inc.$485
Terumo Medical Corporation$359
Inari Medical, Inc.$227
Boston Scientific$132
plus $223 from 2 others

What the payments were for

Speaking & faculty fees$501%
Travel & lodging$1,57037%
Food & beverage$2,23453%
Education$3578%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Angiodynamics, Inc.	2	$1,913
Medtronic(2 entities)	30	$871
Bard Peripheral Vascular, Inc.	11	$485
Terumo Medical Corporation	4	$359
Inari Medical, Inc.	1	$227
Boston Scientific	6	$132
Cashflow Solutions, LLC	9	$131
Sirtex Medical Inc	1	$92

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,211 in reported general payments places this provider in the 55th percentile of 299 vascular & interventional radiology providers in Texas.

See all vascular & interventional radiology providers in Texas →

Medicare billing

Part B allowed, 2024

$389,531

Medicare patients

140

Services billed

1,006

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other vascular & interventional radiology in Flower Mound

Armeen MahvashHouston$2.6M
Rony AvritscherHouston$1.3M
Orlando DiazHouston$699K
Sanjeeva KalvaDallas$581K
Rahul ShethHouston$511K
Miguel MonteroHouston$482K
Marshall HicksHouston$403K
Ahmed Abdel AalHouston$372K
Joshua KubanHouston$349K
Patrick SutphinDallas$346K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →